FOXP3 and esophageal adenocarcinoma: The number of FoxP3+ T cells in the stroma of esophageal adenocarcinoma correlates with later stage and poor response to therapy [12,13], while a large amount of FoxP3 in the stroma of ESCC correlates with a good prognosis [14].